Emphasis on high-density lipoprotein cholesterol in patients with coronary artery disease

Mailander, Lois, Lavie, Carl J., Milani, Richard V. and Gaudin, Dana (1993) Emphasis on high-density lipoprotein cholesterol in patients with coronary artery disease. Southern Medical Journal, 86 5: 508-512. doi:10.1097/00007611-199305000-00004

Author Mailander, Lois
Lavie, Carl J.
Milani, Richard V.
Gaudin, Dana
Title Emphasis on high-density lipoprotein cholesterol in patients with coronary artery disease
Journal name Southern Medical Journal   Check publisher's open access policy
ISSN 0038-4348
Publication date 1993-05
Sub-type Article (original research)
DOI 10.1097/00007611-199305000-00004
Volume 86
Issue 5
Start page 508
End page 512
Total pages 5
Place of publication Philadelphia, PA, United States
Publisher Lippincott Williams & Wilkins
Language eng
Formatted abstract
Although numerous epidemiologic and lipid intervention studies clearly demonstrate the pivotal role of high-density lipoprotein cholesterol (HDL-C) on risk of coronary artery disease (CAD), the National Cholesterol Education Program (NCEP) has emphasized only total cholesterol and low-density lipoprotein cholesterol (LDL-C), and has underemphasized the role of HDL-C in their lipid assessment and treatment recommendations. In a review of 113 consecutive patients in our cardiac rehabilitation program, lipid levels improved modestly with cardiac rehabilitation. 'Ideal' lipids (LDL-C <130 mg/dL according to the NCEP) were present in 49% before the rehabilitation program and in 46% afterward. In fact, 60 (53%) of our patients had total cholesterol levels <200 mg/dL and would require no further lipid assessment or treatment according to the NCEP. Of these 60 patients, 40 (67%) had low HDL-C (≤35 mg/dL). In our total study group, 56% (63/113) had HDL-C ≤35 mg/dL and 33% (37/113) had HDL-C ≤30 mg/dL before rehabilitation (compared to 42% and 21%, respectively, after rehabilitation. On the other hand, a 'high-risk' LDL-C value (≥160 mg/dL) was found in only 17% of patients at baseline and in only 13% after the cardiac rehabilitation program. Using an approach that incorporates the pivotal role of both LDL-C and HDL-C (LDL-C ≥160 mg/dL or HDL-C ≤35 mg/dL) for our patients with known CAD, 65% would require drug treatment before rehabilitation and 53% after rehabilitation. We conclude that: (1) lipids improve only modestly (though the change is significant statistically) with cardiac rehabilitation; (2) low levels of HDL-C are prevalent in cardiac rehabilitation patients and are much more prevalent than elevated LDL-C, both before and after rehabilitation; and (3) the NCEP should reevaluate the pivotal role of HDL-C in its assessment and treatment guidelines, particularly in patients with known CAD, since emphasis on both LDL-C and HDL-C is needed for optimal primary and secondary prevention of CAD.
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Medicine Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 2 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Mon, 14 Mar 2011, 09:33:37 EST